A 32-year-old man from Mumbai presents with a 3-week history of fever, night sweats, and progressive dyspnea. He is known to be HIV-positive with a CD4 count of 85 cells/μL (measured 2 weeks ago). On examination, he has bilateral crackles on auscultation. Chest X-ray shows bilateral interstitial infiltrates with a ground-glass appearance. Arterial blood gas shows PaO₂ 65 mmHg on room air. He has not been on antiretroviral therapy (ART) or prophylaxis. What is the most likely diagnosis?

Explanation

## Clinical Presentation and Diagnosis **Key Point:** PCP is the most common opportunistic infection in HIV patients with CD4 <100 cells/μL, presenting with insidious onset of fever, dyspnea, and dry cough over weeks. ### Diagnostic Features of PCP | Feature | PCP | TB | CMV | Bacterial | |---------|-----|----|----|----------| | CD4 threshold | <100 | <50 (late) | <50 | Variable | | Onset | Insidious (weeks) | Subacute/chronic | Acute/fulminant | Acute (days) | | CXR pattern | Bilateral interstitial/ground-glass | Upper lobe cavitation/miliary | Diffuse infiltrates ± CMV retinitis | Lobar consolidation | | PaO₂ drop | Marked (A-a gradient >35) | Variable | Severe | Mild | | Sputum/BAL | Foamy, frothy | AFB positive | Viral inclusions | Bacterial growth | **High-Yield:** The **ground-glass interstitial pattern** on CXR combined with **marked hypoxemia (PaO₂ 65)** and **CD4 <100** is pathognomonic for PCP. ### Pathophysiology 1. Pneumocystis jirovecii (formerly P. carinii) colonizes the lungs when CD4 <100 cells/μL 2. Trophozoites and cysts accumulate in alveoli → foamy exudate 3. Interstitial inflammation → impaired gas exchange 4. Alveolar-arterial (A-a) gradient widens disproportionately to CXR findings **Clinical Pearl:** PCP classically presents with **dyspnea out of proportion to CXR findings** — a normal or minimally abnormal CXR does NOT exclude PCP; clinical suspicion + hypoxemia warrants empiric treatment. ### Diagnostic Confirmation - **Gold standard:** Bronchoscopy with bronchoalveolar lavage (BAL) and immunofluorescence staining (silver stain, Giemsa, or monoclonal antibodies) - **Serum LDH:** Elevated (often >400 IU/L), supports diagnosis but not specific - **Induced sputum:** Less sensitive than BAL but non-invasive screening tool ### Management **First-line:** Trimethoprim-sulfamethoxazole (TMP-SMX) 15–20 mg/kg/day IV or PO for 21 days **Adjunctive:** Corticosteroids (prednisone 40 mg BD × 5 days, then taper) if PaO₂ <70 or A-a gradient >35 — reduces mortality by ~40% **Prophylaxis:** TMP-SMX DS daily (or alternatives: dapsone, atovaquone-proguanil) when CD4 <100; continue until CD4 >200 for ≥3 months on ART **Key Point:** Initiate ART immediately after PCP treatment stabilizes (within 2 weeks) to restore CD4 count and prevent relapse.